Opportunity

SAM #75F40126SS131706

FDA Seeks Biopharmaceutics Classification System / Automated Solubility Apparatus

Buyer

FDA Office of the Associate General Counsel for Administrative Law

Posted

July 06, 2026

Respond By

July 16, 2026

Identifier

75F40126SS131706

NAICS

334516

The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ), is seeking sources for a Biopharmaceutics Classification System (BCS) / Automated Solubility Apparatus. - Government Buyer: - Agency: U.S. Food and Drug Administration - Sub-agency: Center for Drug Evaluation and Research (CDER) - Office: Office of Pharmaceutical Quality (OPQ) - Products Requested: - Biopharmaceutics Classification System (BCS) / Automated Solubility Apparatus - Quantity: 1 - Must be newly manufactured, latest model, and made in America - Technical requirements: - Maintains sample temperature at 37°C - Adjustable stirring speed - Operates multiple sample containers simultaneously - Withdraws samples at different time points - Filters or centrifuges samples before sampling - Optional features: dilution, pH monitoring, direct HPLC connection - Includes delivery, installation, on-site training for 6 scientists, and minimum one-year warranty (parts and labor) - Services Requested: - Delivery, installation, on-site performance testing, and training for at least 6 scientists - Support for network computer - Unique Requirements: - Apparatus must be made in America - On-site training and warranty included - OEMs and Vendors: - No specific OEMs or vendors are named; opportunity is open to manufacturers meeting requirements

Description

See Attached Sources Sought 75F40126SS131706

View original listing